Immunophenotype
Showing 1 - 25 of 242
Sepsis, Septic Shock, Sepsis Syndrome Trial in Nanjing
Enrolling by invitation
- Sepsis
- +2 more
-
Nanjing, Jiangsu, ChinaDepartment of Critical Care , Zhong-da Hospital
Oct 29, 2022
Immune-related Adverse Events Refractory to Standard Therapy and
Recruiting
- Immune-related Adverse Event
- Extracorporeal photopheresis
- Other immunosuppressive or immunomodulatory drugs
-
Munich, GermanyLMU Klinikum Hauttumorzentrum
Jan 17, 2023
Circulating and Tumor-infiltrating Immune Cells in Malignant
Recruiting
- Brain Tumor, Primary
- Brain Tumor - Metastatic
- Circulating leukocytes immunophenotype
- Tumor sampling
-
Milan, ItalyIRCCS San Raffaele Scientific Institute
Apr 14, 2023
Immunophenotype of Risk in Older Patients Admitted for Pneumonia
Active, not recruiting
- Age Associated Immune Deficiency
- +5 more
- no intervention
-
Barcelona, SpainHospital de la Santa Creu i Sant Pau
Nov 22, 2021
Leukocyte Immunophenotype and Lipid Transport System as
Unknown status
- Sepsis
- +2 more
- Bood leukocyte subsets
- The cholesterol content of the cell membrane of T-cells and monocytes
-
Minsk, BelarusThe Republican Research and Practical Center for Epidemiology an
Nov 24, 2019
B-All, Acute Lymphoblastic Leukemia Trial run by the National Cancer Institute (NCI) (NGS testing)
Not yet recruiting
- B-All
- Acute Lymphoblastic Leukemia
- NGS testing
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Feb 2, 2023
Gastric Cancer Trial in ZhengZhou (SHR1210 combined with FOLFOX)
Active, not recruiting
- Gastric Cancer
- SHR1210 combined with FOLFOX
-
ZhengZhou, Henan, ChinaHenan Cancer Hospital/The affiliated Cancer Hospital of ZhengZho
Jan 11, 2022
Tumor Microenvironment
Active, not recruiting
- Lung Adenocarcinoma
- (no location specified)
Aug 5, 2023
AML Patients After Stem Cell Transplant to Understand Relapse
Recruiting
- Acute Myeloid Leukemia in Remission
- Prospective determination of the clinical utility of measurable residual disease (MRD) testing
-
Duarte, California
- +3 more
Dec 7, 2022
Malignant Sarcoma Trial in Madrid (Natural Killer (NK) cells (a new immunotherapy))
Recruiting
- Malignant Sarcoma
- Natural Killer (NK) cells (a new immunotherapy)
-
Madrid, SpainHospital Universitario La Paz
Jul 19, 2023
Acute Myeloid Leukemia Trial in Columbus (Universal Donor Natural Killer Cells)
Recruiting
- Acute Myeloid Leukemia
- Universal Donor Natural Killer Cells
-
Columbus, OhioNationwide Children's Hospital
Aug 11, 2022
Endometriosis, Endometriosis-related Pain Trial in Milan (Blood, fecal, vaginal and endometrial liquid samples)
Recruiting
- Endometriosis
- Endometriosis-related Pain
- Blood, fecal, vaginal and endometrial liquid samples
-
Milan, ItalyFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Jun 22, 2022
CLL/SLL Trial in France (First line therapy)
Not yet recruiting
- CLL/SLL
- First line therapy
-
Amiens, France
- +57 more
Oct 21, 2022
T-Acute Lymphoblastic Leukemia, Adult T Lymphoblastic Lymphoma Trial in United States (BL-8040, Nelarabine)
Terminated
- T-Acute Lymphoblastic Leukemia
- Adult T Lymphoblastic Lymphoma
-
Saint Louis, Missouri
- +1 more
Jan 18, 2023
Primary Sclerosing Cholangitis Trial in Redwood City, Stanford (Hymecromone)
Not yet recruiting
- Primary Sclerosing Cholangitis
-
Redwood City, California
- +1 more
Nov 1, 2022
Anaplastic Lymphoma Kinase Gene Translocation, NSCLC Trial in Boston
Recruiting
- Anaplastic Lymphoma Kinase Gene Translocation
- Non-Small Cell Lung Cancer
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Jan 14, 2022
Adjuvant Radiotherapy of Non-metastatic Breast Carcinoma With
Recruiting
- Tumor Cell, Circulating
- Adjuvant radiotherapy
- neoadjuvant and adjuvant chemotherapy
-
Jena, GermanyDepartment of Radiooncology, Jena
Sep 28, 2021
Immunological Disease, Autoimmune Diseases, Primary Immune Deficiency Trial in New York
Recruiting
- Immunological Disease
- +2 more
-
New York, New YorkMount Sinai
Apr 13, 2022
HIV Infection Trial in Italy, Netherlands, Spain (Analytical Treatment Interruption + bNAbs infusion)
Withdrawn
- HIV Infection
- Analytical Treatment Interruption + bNAbs infusion
-
Milan, Lombardy, Italy
- +3 more
Aug 2, 2022
Knee Arthroplasty, Total Trial in Vail (Losartan, Placebo - Losartan)
Not yet recruiting
- Knee Arthroplasty, Total
- Losartan
- Placebo - Losartan
-
Vail, ColoradoThe Steadman Clinic
Oct 26, 2023
Recurrent Multiple Myeloma, Refractory Multiple Myeloma Trial in Columbus (procedure, drug, biological)
Not yet recruiting
- Recurrent Multiple Myeloma
- Refractory Multiple Myeloma
- Biospecimen Collection
- +9 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Aug 1, 2023
Recurrent Ovarian Carcinoma, Platinum-resistant Ovarian Cancer Trial in Beijing (6B11-OCIK Injection, Doxorubicin)
Recruiting
- Recurrent Ovarian Carcinoma
- Platinum-resistant Ovarian Cancer
- 6B11-OCIK Injection
- Doxorubicin
-
Beijing, ChinaPeking University People's hospital
Feb 11, 2022
Multiple Myeloma, Plasma Cell Tumor, Malignant Plasma Cell Tumor Trial in Houston (Radiation Therapy)
Recruiting
- Multiple Myeloma
- +2 more
- Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jul 9, 2022